Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonazepam in ARID1B-related intellectual disability
ISRCTN11225608Phase 4Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clonazepam in ARID1B-related intellectual disability (ARID1B-ID) (3 arms), sponsored by Centre for Human Drug Research. Started Feb 2022; status: completed.
02
Drugs
clonazepam
03
Conditions
ARID1B-related intellectual disability (ARID1B-ID)
Beyond the preview
Go deeper on ISRCTN11225608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11225608.